GLOBUS MEDICAL, INC. Cost of Revenue
GLOBUS MEDICAL, INC. (GMED) reported Cost of Revenue of $241.44 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-06
- GLOBUS MEDICAL, INC. cost of goods and services sold for the quarter ending 2026-06-30 was $241.44M, a 2.94% decline year-over-year.
- GLOBUS MEDICAL, INC. cost of goods and services sold for the quarter ending 2026-03-31 was $234.07M, a 19.79% increase year-over-year.
- GLOBUS MEDICAL, INC. cost of goods and services sold for the quarter ending 2025-12-31 was $261.11M, a 0.88% decline year-over-year.
- GLOBUS MEDICAL, INC. cost of goods and services sold for the quarter ending 2025-09-30 was $252.53M, a 6.65% decline year-over-year.
- GLOBUS MEDICAL, INC. cost of goods and services sold for fiscal 2025 was $957.80M, a 7.50% decline from fiscal 2024.
- GLOBUS MEDICAL, INC. cost of goods and services sold for fiscal 2024 was $1.04B, a 88.90% increase from fiscal 2023.
- GLOBUS MEDICAL, INC. cost of goods and services sold for fiscal 2023 was $548.17M, a 107.86% increase from fiscal 2022.
- GLOBUS MEDICAL, INC. cost of goods and services sold for fiscal 2022 was $263.73M, a 10.24% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 9 month as first filed | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $241.44M 10-Q · filed 2026-08-06 | $475.50M 10-Q · filed 2026-08-06 | $736.61M derived: sum of 3 quarters · filed 2026-08-06 | $989.14M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $234.07M 10-Q · filed 2026-05-07 | $495.17M derived: sum of 2 quarters · filed 2026-05-07 | $747.71M derived: sum of 3 quarters · filed 2026-05-07 | $996.47M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $261.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $513.64M derived: sum of 2 quarters · filed 2026-02-24 | $762.40M derived: sum of 3 quarters · filed 2026-08-06 | $957.80M 10-K · filed 2026-02-24 | |
| 2025-09-30 | $252.53M 10-Q · filed 2025-11-06 | $501.30M derived: sum of 2 quarters · filed 2026-08-06 | $696.70M 10-Q · filed 2025-11-06 | $960.13M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $248.76M 10-Q · filed 2026-08-06 | $444.16M 10-Q · filed 2026-08-06 | $707.60M derived: sum of 3 quarters · filed 2026-08-06 | $978.11M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $195.40M 10-Q · filed 2026-05-07 | $458.83M derived: sum of 2 quarters · filed 2026-05-07 | $729.35M derived: sum of 3 quarters · filed 2026-05-07 | $989.39M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $263.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $533.95M derived: sum of 2 quarters · filed 2026-02-24 | $793.99M derived: sum of 3 quarters · filed 2026-02-24 | $1.04B 10-K · filed 2026-02-24 | |
| 2024-09-30 | $270.51M 10-Q · filed 2025-11-06 | $530.55M derived: sum of 2 quarters · filed 2025-11-06 | $772.04M 10-Q · filed 2025-11-06 | $1.04B derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-06-30 | $260.04M 10-Q · filed 2025-08-07 | $501.53M 10-Q · filed 2025-08-07 | $767.01M derived: sum of 3 quarters · filed 2026-02-24 | $902.40M derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-03-31 | $241.49M 10-Q · filed 2025-05-08 | $506.97M derived: sum of 2 quarters · filed 2026-02-24 | $642.36M derived: sum of 3 quarters · filed 2026-02-24 | $718.84M derived: sum of 4 quarters · filed 2026-02-24 | |
| 2023-12-31 | $265.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $400.88M derived: sum of 2 quarters · filed 2026-02-24 | $477.35M derived: sum of 3 quarters · filed 2026-02-24 | $548.17M 10-K · filed 2026-02-24 | |
| 2023-09-30 | $135.39M 10-Q · filed 2024-11-05 | $211.86M derived: sum of 2 quarters · filed 2024-11-05 | $282.69M 10-Q · filed 2024-11-05 | $353.28M derived: sum of 4 quarters · filed 2025-02-20 | |
| 2023-06-30 | $76.47M 10-Q · filed 2024-08-06 | $147.30M 10-Q · filed 2024-08-06 | $217.89M derived: sum of 3 quarters · filed 2025-02-20 | $283.39M derived: sum of 4 quarters · filed 2025-02-20 | |
| 2023-03-31 | $70.83M 10-Q · filed 2024-05-07 | $141.42M derived: sum of 2 quarters · filed 2025-02-20 | $206.91M derived: sum of 3 quarters · filed 2025-02-20 | $275.38M derived: sum of 4 quarters · filed 2025-02-20 | |
| 2022-12-31 | $70.59M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $136.09M derived: sum of 2 quarters · filed 2025-02-20 | $204.56M derived: sum of 3 quarters · filed 2025-02-20 | $263.73M 10-K · filed 2025-02-20 | |
| 2022-09-30 | $65.50M 10-Q · filed 2023-11-07 | $133.97M derived: sum of 2 quarters · filed 2023-11-07 | $193.13M 10-Q · filed 2023-11-07 | $254.93M derived: sum of 4 quarters · filed 2024-02-21 | |
| 2022-06-30 | $68.47M 10-Q · filed 2023-08-03 | $127.64M 10-Q · filed 2023-08-03 | $189.43M derived: sum of 3 quarters · filed 2024-02-21 | $247.99M derived: sum of 4 quarters · filed 2024-02-21 | |
| 2022-03-31 | $59.17M 10-Q · filed 2023-05-04 | $120.96M derived: sum of 2 quarters · filed 2024-02-21 | $179.52M derived: sum of 3 quarters · filed 2024-02-21 | $243.36M derived: sum of 4 quarters · filed 2024-02-21 | |
| 2021-12-31 | $61.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $120.35M derived: sum of 2 quarters · filed 2024-02-21 | $184.20M derived: sum of 3 quarters · filed 2024-02-21 | $239.22M 10-K · filed 2024-02-21 | |
| 2021-09-30 | $58.55M 10-Q · filed 2022-11-08 | $122.40M derived: sum of 2 quarters · filed 2022-11-08 | $177.43M 10-Q · filed 2022-11-08 | $238.29M derived: sum of 4 quarters · filed 2023-02-21 | |
| 2021-06-30 | $63.85M 10-Q · filed 2022-08-04 | $118.87M 10-Q · filed 2022-08-04 | $179.73M derived: sum of 3 quarters · filed 2023-02-21 | $236.83M derived: sum of 4 quarters · filed 2023-02-21 | |
| 2021-03-31 | $55.03M 10-Q · filed 2022-05-10 | $115.89M derived: sum of 2 quarters · filed 2023-02-21 | $172.98M derived: sum of 3 quarters · filed 2023-02-21 | $223.63M derived: sum of 4 quarters · filed 2023-02-21 | |
| 2020-12-31 | $60.86M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $117.96M derived: sum of 2 quarters · filed 2023-02-21 | $168.60M derived: sum of 3 quarters · filed 2023-02-21 | $217.46M 10-K · filed 2023-02-21 | |
| 2020-09-30 | $57.10M 10-Q · filed 2021-11-04 | $107.74M derived: sum of 2 quarters · filed 2021-11-04 | $156.60M 10-Q · filed 2021-11-04 | $205.37M derived: sum of 4 quarters · filed 2022-02-17 | |
| 2020-06-30 | $50.64M 10-Q · filed 2021-08-04 | $99.51M 10-Q · filed 2021-08-04 | $148.27M derived: sum of 3 quarters · filed 2022-02-17 | $193.66M derived: sum of 4 quarters · filed 2022-02-17 | |
| 2020-03-31 | $48.86M 10-Q · filed 2021-05-04 | $97.63M derived: sum of 2 quarters · filed 2022-02-17 | $143.01M derived: sum of 3 quarters · filed 2022-02-17 | $187.00M derived: sum of 4 quarters · filed 2022-02-17 | |
| 2019-12-31 | $48.76M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $94.15M derived: sum of 2 quarters · filed 2022-02-17 | $138.14M derived: sum of 3 quarters · filed 2022-02-17 | $179.97M 10-K · filed 2022-02-17 | |
| 2019-09-30 | $45.39M 10-Q · filed 2020-10-28 | $89.38M derived: sum of 2 quarters · filed 2020-10-28 | $131.21M 10-Q · filed 2020-10-28 | $131.22M derived: sum of 4 quarters · filed 2021-02-17 | |
| 2019-06-30 | $43.99M 10-Q · filed 2020-08-05 | $85.83M 10-Q · filed 2020-08-05 | $85.83M derived: sum of 3 quarters · filed 2021-02-17 | $123.68M derived: sum of 4 quarters · filed 2021-02-17 | |
| 2019-03-31 | $41.84M 10-Q · filed 2020-05-07 | $41.84M derived: sum of 2 quarters · filed 2021-02-17 | $79.69M derived: sum of 3 quarters · filed 2021-02-17 | $117.32M derived: sum of 4 quarters · filed 2021-02-17 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-K 9 month · filed 2021-02-17 | $37.85M derived: sum of 2 quarters · filed 2021-02-17 | $75.49M derived: sum of 3 quarters · filed 2021-02-17 | $159.41M 10-K · filed 2021-02-17 | |
| 2018-09-30 | $37.85M 10-Q · filed 2019-11-06 | $75.49M derived: sum of 2 quarters · filed 2019-11-06 | $159.41M 10-K · filed 2020-02-20 | $113.46M 10-Q · filed 2018-11-08 | $154.31M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $37.64M 10-Q · filed 2019-08-01 | $75.61M 10-Q · filed 2019-08-01 | $116.46M derived: sum of 3 quarters · filed 2020-03-02 | $153.26M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-03-31 | $37.97M 10-Q · filed 2019-05-02 | $78.83M derived: sum of 2 quarters · filed 2020-03-02 | $115.62M derived: sum of 3 quarters · filed 2020-03-02 | $152.82M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2017-12-31 | $40.86M derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-03-02 | $77.65M derived: sum of 2 quarters · filed 2020-03-02 | $114.85M derived: sum of 3 quarters · filed 2020-03-02 | $150.45M 10-K/A · filed 2020-03-02 | |
| 2017-09-30 | $36.80M 10-Q · filed 2018-11-08 | $74.00M derived: sum of 2 quarters · filed 2018-11-08 | $109.60M 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | $37.20M 10-Q · filed 2018-08-02 | $72.80M 10-Q · filed 2018-08-02 | |||
| 2016-12-31 | $134.71M 10-K · filed 2019-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |